Chronic myeloid leukemia (CML) is the third-most common leukemia in children. It is much more common in adults. This slow-moving cancer occurs when excessive numbers of bone marrow stem cells develop into white blood cells and crowd out other cells that produce red blood cells and platelets in the bone marrow. Often, patients are diagnosed when they have few or no symptoms but are undergoing blood tests done for other reasons.
Leukemia is cancer of the blood cells when the bone marrow, where blood cells are made, makes cells that are abnormal in growth and function. The three general types of leukemias found in children are acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML) and chronic myelogenous leukemia (CML).
Patient and Family Education Materials If you need quick, clear info about a kids' health topic, we have it all!
If your child is diagnosed with cancer or a blood disorder, we understand it's not easy news to hear, but know that Children's Minnesota will be with you and your child along every step of the way. We believe that by providing the best journey for the patient and family, it will lead to the best outcomes. You'll receive first-rate, compassionate care from the moment we meet.
The cancer and blood disorders team at Children's Minnesota has the training, knowledge and technology to treat a wide range of conditions. Nearly 900 children are admitted annually as inpatients to the Jim and Colleen Ryan Pediatric Cancer and Blood Disorders Center at Children's Minnesota in Minneapolis, making us the largest program in the upper midwest. And while we're known as a leader and innovator in the field of pediatric cancer and blood disorder treatment, we never forget that each patient is someone's child. Compassion always factors into our approach. We are on the journey with you, because we believe that better journeys lead to better outcomes.
It can be frightening to hear that a child has cancer or a blood disorder. At Children's Minnesota, we're experts in treating the disease and supporting the patient and family. In addition to offering advanced, individualized care for newly diagnosed children, teens and young adults up to age 26 with cancers and blood disorders, we also provide innovative treatment for rare, relapsed and recurrent cancers.